Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 163

    1.

    Avoiding nocturnal hypoglycemia: consideration of an extra injection at bedtime.

    Norris AW, Laffel LM.

    Ann Intern Med. 2002 Apr 2;136(7):547-9. No abstract available. PMID: 11926791 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial.

    Fanelli CG, Pampanelli S, Porcellati F, Rossetti P, Brunetti P, Bolli GB.

    Ann Intern Med. 2002 Apr 2;136(7):504-14.PMID: 11926785 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Summary for patients. Splitting the evening insulin dose to avoid low blood sugar levels and to improve sugar control in patients with type 1 diabetes.

    [No authors listed]

    Ann Intern Med. 2002 Apr 2;136(7):I29. No abstract available. PMID: 11926807 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen.

    Mohn A, Strang S, Wernicke-Panten K, Lang AM, Edge JA, Dunger DB.

    Diabetes Care. 2000 Apr;23(4):557-9. No abstract available. PMID: 10857953 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.

    Russell-Jones D, Simpson R, Hylleberg B, Draeger E, Bolinder J.

    Clin Ther. 2004 May;26(5):724-36.PMID: 15220016 [PubMed - indexed for MEDLINE]Related articles

    7.

    Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy.

    Albright ES, Desmond R, Bell DS.

    Diabetes Care. 2004 Feb;27(2):632-3. No abstract available. PMID: 14747268 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.
    9.

    The 12-month efficacy and safety of insulin detemir and NPH insulin in basal-bolus therapy for the treatment of type 1 diabetes.

    Standl E, Lang H, Roberts A.

    Diabetes Technol Ther. 2004 Oct;6(5):579-88.PMID: 15628811 [PubMed - indexed for MEDLINE]Related articles

    10.

    Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine hagedorn insulin in patients with type 2 diabetes.

    Linn T, Fischer B, Soydan N, Eckhard M, Ehl J, Kunz C, Bretzel RG.

    J Clin Endocrinol Metab. 2008 Oct;93(10):3839-46. Epub 2008 Jul 8.PMID: 18611975 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Comparison of breakfast and bedtime administration of insulin glargine in children and adolescents with Type 1 diabetes.

    Karagüzel G, Satilmiş A, Akçurin S, Bircan I.

    Diabetes Res Clin Pract. 2006 Oct;74(1):15-20. Epub 2006 Apr 18.PMID: 16621116 [PubMed - indexed for MEDLINE]Related articles

    13.

    Nocturnal hypoglycemia in children with diabetes: an important problem revisited.

    Santiago JV.

    J Pediatr. 1997 Jul;131(1 Pt 1):2-4. No abstract available. PMID: 9255180 [PubMed - indexed for MEDLINE]Related articles

    14.

    Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens.

    Murphy NP, Keane SM, Ong KK, Ford-Adams M, Edge JA, Acerini CL, Dunger DB.

    Diabetes Care. 2003 Mar;26(3):799-804.PMID: 12610040 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

    Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

    Clin Ther. 2004 Apr;26(4):502-10.PMID: 15189747 [PubMed - indexed for MEDLINE]Related articles

    16.

    Twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn therapy for newly diagnosed type 1 diabetes.

    Al Shamsi AM.

    Pediatrics. 2008 Sep;122(3):675-6; author reply 676. No abstract available. PMID: 18762540 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    [New insulin with uniform action. Hazards of blood sugar variations minimized]

    [No authors listed]

    MMW Fortschr Med. 2003 Oct 2;145(40):55. German. No abstract available. PMID: 14603609 [PubMed - indexed for MEDLINE]Related articles

    18.

    Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes.

    Sargin H, Sargin M, Altuntaş Y, Sengül AM, Orbay E, Seber S, Uçak S, Yayla A.

    Diabetes Res Clin Pract. 2003 Nov;62(2):79-86.PMID: 14581144 [PubMed - indexed for MEDLINE]Related articles

    19.

    Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.

    Deiss D, Kordonouri O, Hartmann R, Hopfenmüller W, Lüpke K, Danne T.

    Pediatr Diabetes. 2007 Jun;8(3):157-62.PMID: 17550426 [PubMed - indexed for MEDLINE]Related articles

    20.

    Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.

    Fulcher GR, Gilbert RE, Yue DK.

    Intern Med J. 2005 Sep;35(9):536-42.PMID: 16105155 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data